Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:45PM GMT
Release Date Price: $26.8 (+1.02%)
Anupam Rama JPMorgan;Analyst

Welcome everyone, to the 42nd Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan, joined by my squad, [Laurel Hall], Priyanka Grover, [Malcom Kunal]. Our next presenting company is Zai Lab. Presenting on behalf of the company, we've CEO, Samantha Du. Samantha?

Samantha Du Zai Lab Ltd;Founder
Chairperson & CEO

Thank you Anupam. Thank you for inviting me to this conference. And also, good morning everyone. And really look forward to spending the rest of the 20 minutes or whatever -- 40 minutes with you. And I see a lot of familiar faces in the audience. Also, I see some faces new. So for those of you who are not familiar with Zai story, I'll just give a quick introduction.

Zai Lab was found at -- first of all, my name is Samantha Du, CEO and founder of Zai Lab. The company was started 10 years ago. Our mission at the time, still now, is to form an innovative biopharma company started from China, then to the rest of the world. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot